Cannetics is a completely pesticide-free cannabis cultivation facility. We test all our badges for pesticides, heavy metals, alfatoxins, microbials, etc. to ensure that our clients will only receive the cleanest and best possible quality cannabis product. We take pride in our work, and it shows. Every time you order our products, we guarantee that it will be an experience worth having.
Many companies are overly focused on simply bringing ultra-high - THC, CBD and a combo of both - strains. The cannabis plant is very complex and contain many different chemical compounds e.g. cannabinoids, flavonoids and terpenoids totalling over 500 different compounds. The combination of those and the different profiles of various compound groups are what makes for visual appearance, aromatic impressions and ultimately patient treatment.
Cannetics have strong focus on this area and has access to a wide variety of strains worldwide and from our partners’ profile banks and will be able to bring some of the best genes to Denmark. Cannetics and partners are constantly working on new strains.
The most recent data released by Sundhedsdatastyrelsen showed that in Q2 2018 only around 400 prescriptions for cannabis products were used per month across all pharmacies. The market is obviously new and is consistently increasing, but at a conservative rate; Danish doctors are still reluctant to prescribing cannabis due to a general lack of knowledge about the plant as medicine and long-term effects of use. Ultimately, there is an estimated current market potential of approximately 1,400,000 people categorized as following:
Arthritis & chronic pain: More than 850,000.
Cancer: Approx. 280,000. About 1/3 of the Danish population gets diagnosed.
Stress: Approx. 250,000
Epilepsy: Approx. 50,000. 5000 diagnosed /yr.
Multiple sclerosis: Approx. 16,000. 650 diagnosed /yr.
Parkinson: Approx. 7500
Autism: Unknown
The number of conditions treated using medical marijuana is growing rapidly, as new patients are added to the market and more knowledge is acquired, the demand for medical marijuana is expected to increase multiple folds over the forecast period.
Cannetics are establishing partnerships with corporations that are leading in the field of research regarding medical cannabis. Partners in both Israel and Canada.